~gd said:
Ever heard of Haemophilus influenzae serotype b infection? usually called HIB disease. Nasty infection that came on so fast with a high fever that it would fry baby brains before they got in for treatment used to average 10,000 deaths/year with another 50,000 suffering Retardation or deafness caused by the high fever. It was a bacteria that could be controlled by antibiotics if treated early. You mothers know the drill, baby is fussy and falls off to sleep. wakes screaming with a fever and you try to get in to see a doctor or go to the ER. If they run tests before the antibiotic, baby is doomed it was just that fast moving in infants. Now there are usually about 10 cases a year, most of them fatal as docs won't shoot antibiotics without knowing what they are shooting at and most docs have never seen a case.
poliomyelitis- We have all heard about the Salk (Injected) vaccine but it was the Sabin (oral) vaccine that really cleared it out of the USA and now most of the world.
Greatly reduced would be diphtheria, pertussis, tetanus.
measles, mumps, rubella, influenza and pneumococcal pneumonia, the last one I worked on before I retired.~gd
During the 70's and 80's there were an estimated 16000-20000 Hib infections per year. (National institute of health)
around 25% of cases cause hearing loss, neurological problems or pneumonia. Inflamation of the throat accounted for nearly 15% of cases. The mortality rate was about 4% (Pediatric journal of infectious disease, 1987 page 775-778)
Hib infections occurred at a much lower rate during the 40's and 50s In fact Hib rates jumped 400% between 1946 and 1986 a period coinciding with mass use of the DPT vaccine.
Rates Tumbled beginning in the 90's with just 329 cases of Hib in american children under 5 years old. in 1994, 259 cases and in 1996 and 1997 144 cases combined.
60% of cases occur in children less than 12 months of age, 90 % children under 5 years old.
Children are at risk of contracting Hib following their vaccination, doctors have been warned by the CDC that cases may occur, after vaccintion prior to protection from the shot. Studies warn of Increased susceptibility to the disease during the first 7 days following the vaccination.
Several studies have found Hib vaccinated children are 6 times more likely to contract Hib after vaccination, than unvaccinated children.
One study showed 70% of those who contracted Hib after being vaccinated, developed Meningitis.
Additional research has confirmed Hib vaccination, even with the newer conjugated vaccine, placing the child at greater risk for invasive disease.
Hib vaccine has been linked to serious ailments including: Guillain Barre syndrom, transverse myelitis, aseptic meningitis, invasice pneumococcal disease, thrombocytopenia, fever, rash, hives, vomiting, diarrhea, seizures, convulsions and SIDS.
The Hib vaccine may also be linked to the new epidemics of diabetes - sharp increases of insulin dependent diabetes mellitus have been recorded in the USA and England, following mass vaccination, with Hib. In a landmark study Finnish children were split into three groups.
The first group recieved no Hib vaccine, The second group received one dose of Hib. The third group received four doses of Hib (at 3, 4 6, and 18 months) At ages seven and ten the total number of cases of type 1 diabetes in all three groups was tallied.
Results: At age 7, there were 54 more cases per 100,000 children in the group that recieved 4 doses of the Hib vaccine, compared to the group that recieved none. a 26% increase. At age 10, there were 58 more cases per 100,000 children in the group that recieved four doses of Hub compared to the group that recieved None.
Based on an annual birth rate of 4 million children, in the US alone, this translates to 2300 additional cases of diabetes every year!
By contrast, the Hib vaccine is expected to prevent a much smaller number of severe disabilities.
Furthermore, the increased risk of diabetes in the vaccinated group, exceeds the expected decrease risk of complications of Hib Meningitis.
Thus the experts issued a warning to the public that in their estimation the potential risk of the vaccine exceeds the potential benifit. (British Medical Journal 1999 page 319 and 1133)